Dexamethasone implant improves anatomic response to anti-VEGF therapy in treatment-resistant polypoidal choroidal vasculopathy.

Kushanth MallikarjunRaja NarayananRajiv RamanAshik MohamedMahesh P ShanmugamRajendra S ApteSrikant Kumar Padhy

Published in: International ophthalmology (2021)

Dexamethasone implant combined with anti-VEGF treatment can prolong the treatment-free interval in eyes with PCV resistant to anti-VEGF injection while maintaining visual acuity.

Keyphrases

vascular endothelial growth factor
endothelial cells
optical coherence tomography
high dose
low dose
stem cells
mesenchymal stem cells
cell therapy
cataract surgery